APA
Renzi S., Michaeli O., Salvador H., Alderete D., Ponce N. F., Zapotocky M., Hansford J. R., Malalasekera V. S., Toledano H., Maguire B., Bouffet E., Ramaswamy V. & Baroni L. V. (20200714). Bevacizumab for NF2-associated vestibular schwannomas of childhood and adolescence. : Pediatric blood & cancer.
Chicago
Renzi Samuele, Michaeli Orli, Salvador Hector, Alderete Daniel, Ponce Nicolas Fernandez, Zapotocky Michal, Hansford Jordan R, Malalasekera Vajiranee S, Toledano Helen, Maguire Bryan, Bouffet Eric, Ramaswamy Vijay and Baroni Lorena V. 20200714. Bevacizumab for NF2-associated vestibular schwannomas of childhood and adolescence. : Pediatric blood & cancer.
Harvard
Renzi S., Michaeli O., Salvador H., Alderete D., Ponce N. F., Zapotocky M., Hansford J. R., Malalasekera V. S., Toledano H., Maguire B., Bouffet E., Ramaswamy V. and Baroni L. V. (20200714). Bevacizumab for NF2-associated vestibular schwannomas of childhood and adolescence. : Pediatric blood & cancer.
MLA
Renzi Samuele, Michaeli Orli, Salvador Hector, Alderete Daniel, Ponce Nicolas Fernandez, Zapotocky Michal, Hansford Jordan R, Malalasekera Vajiranee S, Toledano Helen, Maguire Bryan, Bouffet Eric, Ramaswamy Vijay and Baroni Lorena V. Bevacizumab for NF2-associated vestibular schwannomas of childhood and adolescence. : Pediatric blood & cancer. 20200714.